VITASPRING BIOMEDICAL CO., LTD. Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease)
VITASPRING BIOMEDICAL CO., LTD. (VSBC) reported Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease) of 7.14 million shares for the 12-month period ending 2022-01-31, per its 10-K filed 2022-05-03.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease · last filed 2022-05-03
- VITASPRING BIOMEDICAL CO., LTD. share-based compensation arrangement by share-based payment award, other share increase (decrease) for the quarter ending 2022-01-31 was 0.00 shares.
- VITASPRING BIOMEDICAL CO., LTD. share-based compensation arrangement by share-based payment award, other share increase (decrease) for the quarter ending 2021-10-31 was 0.00 shares.
- VITASPRING BIOMEDICAL CO., LTD. share-based compensation arrangement by share-based payment award, other share increase (decrease) for fiscal 2022 was 7.14M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease) 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease) 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease) 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2022-01-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-03 | 0.00 shares derived: sum of 2 quarters · filed 2022-05-03 | 7.14M shares 10-K · filed 2022-05-03 | |
| 2021-10-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-12-23 | 7.14M shares 10-Q · filed 2021-12-23 | ||
| 2021-07-31 | 7.14M shares 10-Q · filed 2021-09-15 |